HER2 inhibitor Enhertu could become the first drug in the antibody-drug conjugate (ADC) class to be delivered subcutaneously – which is a tall order for such a large molecule – rather than by ...
Seagen claims Enhertu (trastuzumab deruxtecan ... include auristatin compounds coupled to an antibody via a linker molecule. The jury in the US District Court for the Eastern District of ...
The Food and Drug Administration (FDA) has approved Enhertu ® (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback